Showing results (41-50 of 1,877) with videos related to
Sort By:
Pageof 188
EJIFCC|May 6, 2024
Effectiveness of Cord blood as a Strategy to rule out Conjugated HyperbilirubinemiaMiray Kurtca, Sanjiv Harpavat, Sridevi DevarajJournal of Diabetes and Its Complications|April 24, 2012
Human C-reactive protein accentuates macrophage activity in biobreeding diabetic ratsIshwarlal Jialal, Harmeet Kaur, Sridevi DevarajCytokine|April 19, 2011
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetesSridevi Devaraj, Peter Tobias, Ishwarlal JialalThe American Journal of Cardiology|August 23, 2006
Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemiaSridevi Devaraj, Bryce Autret, Ishwarlal JialalCurrent Atherosclerosis Reports|December 16, 2006
Statins and biomarkers of inflammationSridevi Devaraj, Jason Rogers, Ishwarlal JialalThe American Journal of Cardiology|October 24, 2007
Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndromeSridevi Devaraj, David Siegel, Ishwarlal JialalNutrition Reviews|July 4, 2007
Coenzyme Q10 supplementation and heart failureUma Singh, Sridevi Devaraj, Ishwarlal JialalCurrent Atherosclerosis Reports|August 7, 2002
Oxidative stress, alpha-tocopherol therapy, and atherosclerosisAndrea Harris, Sridevi Devaraj, Ishwarlal JialalClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 22, 2020
Activation of the Innate Immune System in Children With Irritable Bowel Syndrome Evidenced by Increased Fecal Human β-Defensin-2Robert J Shulman, Sridevi Devaraj, Margaret HeitkemperHypertension (Dallas, Tex. : 1979)|May 19, 2004
C-reactive protein: risk marker or mediator in atherothrombosis?Ishwarlal Jialal, Sridevi Devaraj, Senthil K VenugopalPageof 188